Cargando…
From ARB to ARNI in Cardiovascular Control
Coexistence of hypertension, diabetes mellitus and chronic kidney disease synergistically aggravates the risk of cardiovascular and renal morbidity and mortality. These high-risk, multi-morbid patient populations benefit less from currently available anti-hypertensive treatment. Simultaneous angiote...
Autores principales: | Uijl, Estrellita, Roksnoer, Lodi C. W., Hoorn, Ewout J., Danser, A. H. Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106495/ https://www.ncbi.nlm.nih.gov/pubmed/27837397 http://dx.doi.org/10.1007/s11906-016-0694-x |
Ejemplares similares
-
Megalin: a Novel Determinant of Renin-Angiotensin System Activity in the Kidney?
por: Sun, Yuan, et al.
Publicado: (2020) -
ARNI versus ACEI/ARB in Reducing Cardiovascular Outcomes after Myocardial Infarction
por: She, Jianqing, et al.
Publicado: (2021) -
Beneficial Effects of Combined AT(1) Receptor/Neprilysin Inhibition (ARNI) Versus AT(1) Receptor Blockade Alone in the Diabetic Eye
por: Prasad, Tuhina, et al.
Publicado: (2016) -
ARBs and risk of cancer: international and South African expert comment
Publicado: (2010) -
Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation
por: Quarti-Trevano, Fosca, et al.
Publicado: (2021)